Meghan E. Sise

9.6k total citations · 1 hit paper
133 papers, 3.7k citations indexed

About

Meghan E. Sise is a scholar working on Hepatology, Oncology and Nephrology. According to data from OpenAlex, Meghan E. Sise has authored 133 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 36 papers in Oncology and 32 papers in Nephrology. Recurrent topics in Meghan E. Sise's work include Hepatitis C virus research (44 papers), Cancer Immunotherapy and Biomarkers (23 papers) and Renal Transplantation Outcomes and Treatments (18 papers). Meghan E. Sise is often cited by papers focused on Hepatitis C virus research (44 papers), Cancer Immunotherapy and Biomarkers (23 papers) and Renal Transplantation Outcomes and Treatments (18 papers). Meghan E. Sise collaborates with scholars based in United States, Germany and Italy. Meghan E. Sise's co-authors include Raymond T. Chung, Jonathan Barasch, Donald F. Chute, Harish Seethapathy, Kerry L. Reynolds, Thomas L. Nickolas, Ian A. Strohbehn, Pietro A. Canetta, Kiyoshi Mori and Nicholas Barasch and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Meghan E. Sise

122 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase–Associated Lipocalin for Diagnosing Acute Kidney Injury

2008 506 citations Meghan E. Sise et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meghan E. Sise United States	32	1.2k	1.1k	1.1k	727	626	133	3.7k
P. Sweny United Kingdom	35	858 0.7×	245 0.2×	1.2k 1.1×	581 0.8×	303 0.5×	120	3.5k
Stefan P. Berger Netherlands	37	1.1k 1.0×	269 0.2×	538 0.5×	247 0.3×	371 0.6×	211	4.3k
Gazi B. Zibari United States	31	392 0.3×	563 0.5×	467 0.4×	520 0.7×	279 0.4×	137	3.6k
Ryutaro Hirose United States	36	278 0.2×	2.2k 1.9×	1.4k 1.4×	537 0.7×	282 0.5×	140	4.9k
Volker Kliem Germany	36	705 0.6×	481 0.4×	1.0k 1.0×	389 0.5×	235 0.4×	99	3.8k
Εvangelos Cholongitas Greece	47	408 0.4×	6.0k 5.2×	5.3k 5.0×	368 0.5×	263 0.4×	192	7.6k
Wooseong Huh South Korea	26	814 0.7×	159 0.1×	482 0.5×	226 0.3×	92 0.1×	178	2.5k
Julie Ho Canada	28	1.1k 1.0×	180 0.2×	718 0.7×	249 0.3×	166 0.3×	88	3.8k
Hani M. Wadei United States	26	469 0.4×	826 0.7×	463 0.4×	254 0.3×	163 0.3×	94	2.3k
Claire Francoz France	38	639 0.6×	5.7k 5.0×	4.4k 4.2×	182 0.3×	186 0.3×	119	7.1k

Countries citing papers authored by Meghan E. Sise

Since Specialization

Citations

This map shows the geographic impact of Meghan E. Sise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan E. Sise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan E. Sise more than expected).

Fields of papers citing papers by Meghan E. Sise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan E. Sise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan E. Sise. The network helps show where Meghan E. Sise may publish in the future.

Co-authorship network of co-authors of Meghan E. Sise

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan E. Sise. A scholar is included among the top collaborators of Meghan E. Sise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan E. Sise. Meghan E. Sise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silva, Verônica T. Costa e, et al.. (2025). Update on the Assessment of GFR in Patients with Cancer. Kidney360. 6(5). 861–870.

Moledina, Dennis G., Wassim Obeid, R. Neal Smith, et al.. (2024). Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. Journal of Clinical Investigation. 134(6). 3 indexed citations

Mistry, Kavita, et al.. (2024). Novel Biomarkers and Imaging Tests for Acute Kidney Injury Diagnosis in Patients with Cancer. Kidney360. 6(1). 167–174.

Shank, Kaitlyn, Aaron J. Deutsch, Natalia Chamorro-Pareja, et al.. (2024). Identification of Immune Checkpoint Inhibitor–Induced Diabetes. JAMA Oncology. 10(10). 1409–1409. 9 indexed citations

Gupta, Shruti, Sofía Martínez, Qiyu Wang, et al.. (2023). Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors. JNCI Journal of the National Cancer Institute. 115(7). 831–837. 8 indexed citations

Sise, Meghan E., Qiyu Wang, Harish Seethapathy, et al.. (2023). Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. Journal for ImmunoTherapy of Cancer. 11(1). e006222–e006222. 23 indexed citations

Strohbehn, Ian A., Sophia Zhao, Qiyu Wang, et al.. (2023). Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study. The Oncologist. 28(6). e379–e390. 7 indexed citations

Short, Samuel, Charlotte Thomas, Dylan J. Martini, et al.. (2023). AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 59(2). 178–188. 3 indexed citations

Moledina, Dennis G., Wassim Obeid, R. Neal Smith, et al.. (2023). Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. Journal of Clinical Investigation. 133(13). 37 indexed citations

10.

Sise, Meghan E., Min Xu, David S. Goldberg, et al.. (2023). Early initiation of glecaprevir/pibrentasvir after transplantation of HCV‐viremic kidneys into HCV‐negative recipients is associated with normalization in the altered inflammatory milieu. Clinical Transplantation. 37(4). e14926–e14926.

11.

Awan, Ahmed A., Marina Berenguer, Annette Bruchfeld, et al.. (2023). Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline. Annals of Internal Medicine. 176(12). 1648–1655. 5 indexed citations

12.

Johnson, P. Connor, Haesook T. Kim, Meghan E. Sise, et al.. (2023). Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(7). 455.e1–455.e9. 3 indexed citations

13.

Zubiri, Leyre, Vartan Pahalyants, Nicholas Theodosakis, et al.. (2022). Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study. Journal for ImmunoTherapy of Cancer. 10(6). e004670–e004670. 53 indexed citations

14.

Murakami, Naoka, Thomas Hills, Hanny Al‐Samkari, et al.. (2022). Therapeutic advances in COVID-19. Nature Reviews Nephrology. 19(1). 38–52. 92 indexed citations

15.

Ferreira, Carolina A., Pedram Heidari, Meghan E. Sise, et al.. (2021). Non-invasive Detection of Immunotherapy-Induced Adverse Events. Clinical Cancer Research. 27(19). 5353–5364. 1 indexed citations

16.

Lee, Meghan, Harish Seethapathy, Orhan Efe, et al.. (2020). Dabrafenib-Induced Acute Interstitial Nephritis (AIN) and AKI in Patients with Cancer. Journal of the American Society of Nephrology. 31(10S). 664–664.

17.

Lee, Meghan, Ian A. Strohbehn, Harish Seethapathy, et al.. (2020). Clinical Features of AKI in Patients Receiving Tisagenlecleucel (CAR-T Therapy). Journal of the American Society of Nephrology. 31(10S). 664–664.

18.

Potluri, Vishnu S., David S. Goldberg, Sumit Mohan, et al.. (2019). National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys. Journal of the American Society of Nephrology. 30(10). 1939–1951. 54 indexed citations

19.

Seethapathy, Harish, Sophia Zhao, Donald F. Chute, et al.. (2019). The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors. Clinical Journal of the American Society of Nephrology. 14(12). 1692–1700. 205 indexed citations

20.

Sise, Meghan E., Harish Seethapathy, & Kerry L. Reynolds. (2019). Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. The Oncologist. 24(6). 735–742. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact